A study on incidence of suspected adverse drug reactions in a tertiary care hospital

---

Original Article

Author Details : Sheeba Damodar KP, Rajiv S, Femijas MP

Volume : 1, Issue : 1, Year : 2016

Article Page : 35-37

Suggest article by email

Get Permission

---

Abstract

Background: An adverse drug reaction (ADR) is an injury caused by taking a medication during the course of the therapy and most of the times are not reported which is a matter of concern.
Objectives: The objective of this study was to find the incidence and prevalence of suspected adverse drug reactions in a tertiary care hospital.
Materials and Methods: Retrospective data collection from the dermatology department over a period of 1 year (2015-2016) and the relevant data was entered in a preformed format and percentage was analysed .we   chose dermatology dept since most of the drug related side effects have cutaneous manifestations.
Results: Most common drug might have caused adverse drug reactions were 21.87% for Amoxicillin or its combinations followed by Phenytoin alone (9.35%) and in combination was 3.12%, followed as a monotherapy was Imatinib mesylate (9.37%), Phenytoin and Carbamazepine was 6.25 respectively and the least as a monotherapy was Allopurinol and Sorafenib constituting 3.12%. Various drugs in other different combinations also caused adverse drug reactions which was 3.12%. 
Conclusion: As per Pharmacovigilance Programme of India (PVPI), it is mandatory to report all related and suspected adverse drug reaction and we opine that either government or private hospital should create awareness in patients as well as the health care professionals about the adverse drug reactions and its importance in reporting the same for taking necessary actions. 

Keywords: Adverse Drug Reactions, Incidence, Retrospective

How to cite : Sheeba Damodar Kp, Rajiv S, Femijas Mp, A study on incidence of suspected adverse drug reactions in a tertiary care hospital. Indian J Clin Anat Physiol 2016;1(1):35-37

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.